Lipid changes during endocrine therapy in early-stage breast cancer patients: A real-world study.

Authors:
Li Y; Deng Z; Wang Y; Shen S.

Journal:
Lipids Health Dis

Publication Year: 2024

DOI:
10.1186/s12944-024-02002-6

PMCID:
PMC10773127

PMID:
38191454

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Lipids Health Dis

Abbreviation: Lipids Health Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Nutrition & Dietetics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Adipokines in atopic dermatitis: the link between obesity and atopic dermatitis.
Zhang S; Zhang B; Liu Y and 1 more (2024) - Transparency Score: 3/6
Adiponectin protects against myocardial ischemia-reperfusion injury: a systematic review and meta-a…
Yue H; Zhang Q; Chang S and 3 more (2024) - Transparency Score: 4/6
A novel lipid metabolism-based risk model associated with immunosuppressive mechanisms in diffuse l…
Zhang Z; Zhao C; Yang S and 2 more (2024) - Transparency Score: 3/6
Appraising associations between signature lipidomic biomarkers and digestive system cancer risk: no…
Sun Y; Cao D; Zhang Y and 6 more (2024) - Transparency Score: 3/6
A regulatory element associated to NAFLD in the promoter of DIO1 controls LDL-C, HDL-C and triglyce…
Castillejo-López C; Bárcenas-Walls JR; Cavalli M and 2 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThis study was approved by the Ethics Committee of PUMCH (approval number: I-22PJ227). All patients signed informed consent. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This study was supported by National Natural Science Foundation of China (52173149), Beijing Natural Science Foundation (7222129) and National High Level Hospital Clinical Research Funding (2022-PUMCH-B-038)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025